Josh helps entrepreneurs build their businesses and advises them on significant transactions in the life cycle of their companies, with a particular focus on fundraising transactions and exit events.
He represents founders, start-ups, and emerging companies, serving as general counsel to those start-ups and emerging companies. Josh advises clients regarding company formation and early-stage legal issues, a broad range of financings, including angel, venture capital, and strategic investments, and mergers and acquisitions. He also provides guidance on legal and business matters that arise in the daily operations of their businesses.
Josh typically works with companies in the life sciences industry — drug development, devices, diagnostics, and tools — and in the technology sector, including energy, digital health, software, and technology-enabled services. He has helped numerous clients, including the following, to grow and thrive:
- Aquinnah Pharmaceuticals
- Asimov
- Axoft
- Bilayer Therapeutics
- Droplette
- Hopewell Therapeutics
- Limax Biosciences
- MediSix Therapeutics
- NanoView Biosciences
- NextGen Jane
- PanTher Therapeutics
- Quaise Energy
- Stemloop
- Suono Bio
- Syntis Bio
- Teal Bio
- Verseau Therapeutics
In addition to counseling entrepreneurs and emerging companies, Josh represents venture capital firms, foundations, and other investors.
Josh frequently speaks about topics related to entrepreneurship, financing, exit strategies, and best practices for businesses. He has also been a lecturer at the Boston University School of Law, teaching a class on venture capital financings that he created.
Josh maintains an active pro bono practice and is involved in the firm’s operations, including hiring activities.
viewpoints
Energy & Sustainability Client Feature — Quaise Energy, Inc.
September 6, 2022 | Article | By Joshua D. Fox
For Second Consecutive Year, Mintz, Mergermarket Publish Life Sciences M&A Report
June 10, 2021 | Article
BAND TOGETHER: Corporate & Cultural Convergence in Life Sciences M&A
June 24, 2020 | | By William Whelan, Joshua D. Fox
News & Press
Mintz Advises Quaise Energy in $21M Series A1 Funding
March 14, 2024
Harvard Law Grads Give Boston Cold Shoulder, Take Jobs Elsewhere
September 11, 2023
Mintz To Support Life Sciences Start-Up Market Through Innovative Relationship With Nucleate Boston
February 20, 2023
Biotech Startups, VCs Seek Path Forward After A Bruising Year
January 12, 2023
Mintz Advises Bio Client Asimov in $200M Fundraising
January 10, 2023
Mintz Leads For Axoft In $8 Million Seed Round Demonstrating Continued Dedication To Biotech Start-Up Market
October 19, 2022
Mintz, Mergermarket Publish Life Sciences M&A Report
June 24, 2020
The article noted that “Osborn and Fox are the latest hires in Mintz’s growing corporate practice, which also had two notable hires in March. The Boston-based firm is enjoying record revenue and profit highs after four straight years of growth.”
Events & Speaking
Recognition & Awards
Chambers USA: Nationwide - Start Ups and Emerging Companies (2023)
Boston Magazine: Top Lawyers – Corporate Law (2021)
Conservation Law Foundation, Legal Food Hub: Distinguished Service Award (2019)
The Legal 500 United States: Recommended for Finance: Capital Markets: Equity Offerings: Advice to Managers (2016)
Boston Magazine: New England Super Lawyers Rising Stars (2008, 2010 – 2016)
Boston Bar Association, Lawyers Committee for Civil Rights Under Law: Civil Rights Recognition Award (2010)
Phi Beta Kappa
Involvement
- Board of Directors, Lawyers for Civil Rights
- Past Member, Board of Visitors, D’Amore-McKim School of Business, Northeastern University
- Past President and Member, Board of Directors, Tufts Lawyers Association
- Past Mentor, BUILD
- Past Member, Leadership Council, Dana-Farber Cancer Institute
- Past Member, Alumni Council, Tufts University